Effect of the imidazoline receptor ligand moxonidine on human platelet aggregation.
Wiest
S A
SA
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Steinberg
M I
MI
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D058647:Adrenergic alpha-2 Receptor Agonists; D003094:Collagen / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000378:metabolism / Q000494:pharmacology*; D054755:Imidazoline Receptors; D008024:Ligands; D010974:Platelet Aggregation / Q000187:drug effects*; D011955:Receptors, Drug / Q000187:drug effects* / Q000378:metabolism
D058647:Adrenergic alpha-2 Receptor Agonists; D007093:Imidazoles; D054755:Imidazoline Receptors; D008024:Ligands; D011955:Receptors, Drug; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D003094:Collagen; C043482:moxonidine